Morgan Stanley’s Picard Medical PMI Stock Holding History
Bought
Maintained
Sold
Other funds holding PMI
VPM
WMP
GSC
Morgan Stanley's PMI Position: Q1 2026 in Review
Morgan Stanley reduced its Picard Medical (PMI) stake by 45% in Q1 2026, selling an estimated $7.51K and leaving 6,376 shares worth $6.63K. The position accounts for ﹤0.01% of the portfolio, ranked #7072.
Morgan Stanley first reported a position in PMI in Q3 2025 and has held it in 3 quarters since. The position peaked at $43K in Q3 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.
- Morgan Stanley held 6,376 shares of Picard Medical worth $6.63K as of Q1 2026.
- Morgan Stanley sold 5,177 Picard Medical shares in Q1 2026, an estimated $7.51K.
- Picard Medical made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #7072 holding.
- Morgan Stanley first reported a position in Picard Medical in Q3 2025 and has held it in 3 quarters since.
- Morgan Stanley's Picard Medical position peaked at $43K in Q3 2025.
- 41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.